Analysts who follow Satsuma Pharmaceuticals Inc (STSA) on average expect it to fall -25.15% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating earns Satsuma Pharmaceuticals Inc an Analyst Ranking of 25, which means it ranks higher than 25 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Satsuma Pharmaceuticals Inc Stock Today?
Satsuma Pharmaceuticals Inc (STSA) stock is higher by 6.88% while the S&P 500 is down -0.34% as of 9:40 AM on Wednesday, Mar 3. STSA has risen $0.43 from the previous closing price of $6.25 on volume of 25,882 shares. Over the past year the S&P 500 has gained 28.43% while STSA is down -74.76%. STSA lost -$2.64 per share the over the last 12 months.
Click Here to get the full report on Satsuma Pharmaceuticals Inc (STSA) Stock.
